Following the recent publicity over questions of safety of insulin analogues, the EMEA is looking into four recently published registry studies
PMLiVE archive subscribers only.
The full content of this article is available to PMLiVE archive subscribers. If you have a current subscription, please use the login box to the left. If you would like to find out more about the PMLiVE archive, please
click here.
